A5046733715- Immunodeficiency and Autoimmune Disorders
- Chronic Lymphocytic Leukemia Research
- Chemotherapy-related skin toxicity
- Respiratory viral infections research
- Hepatitis C virus research
- Streptococcal Infections and Treatments
- Acute Lymphoblastic Leukemia research
- Infections and bacterial resistance
- Escherichia coli research studies
- Antimicrobial Resistance in Staphylococcus
- Wastewater Treatment and Reuse
- Water Treatment and Disinfection
- Intramuscular injections and effects
- Food Security and Health in Diverse Populations
- Syphilis Diagnosis and Treatment
- Liver Disease Diagnosis and Treatment
- Burkholderia infections and melioidosis
- COVID-19 Clinical Research Studies
- Neutropenia and Cancer Infections
- HIV, Drug Use, Sexual Risk
- Antibiotic Resistance in Bacteria
- Opioid Use Disorder Treatment
- Influenza Virus Research Studies
- Immune Response and Inflammation
- Bacterial Identification and Susceptibility Testing
University of British Columbia
2012-2021
Fraser Health
2021
Surrey Memorial Hospital
2014-2018
Office of Infectious Diseases
2009
Powerlink Queensland (Australia)
1996
This article reports a case of 21-year-old woman with refractory B-cell acute lymphocytic leukaemia who presented severe respiratory syndrome coronavirus-2 (SARS-CoV-2). She remained positive for SARS-CoV-2 by viral culture 78 days and polymerase chain reaction (PCR) 97 days. Sequencing repeat samples over time demonstrated an increasing dynamic repertoire mutations.
Despite advances in HCV treatment, recent data on treatment uptake is sparse. and associated factors were evaluated a community-based cohort Vancouver, Canada. The CHASE study of inner city residents recruited from January 2003-June 2004. status retrospectively prospectively determined through linkages with provincial virology pharmacy databases. Logistic regression analyses used to identify uptake. Among 2913, antibody testing was performed 2405, 64% antibody-positive (n = 1533)....
The Downtown Eastside is a robust and densely populated neighbourhood in Vancouver, Canada, that characterized by low-income housing drug use high prevalence of HIV infection. We evaluated mortality excess among the broader community individuals living this neighbourhood.The Community Health Safety Evaluation community-based study inner-city residents who were recruited 2003 2004. Participants' data linked with provincial virology databases retrospectively prospectively for period 1991-2009....
Bacteria of the Burkholderia cepacia complex have rarely been reported to cause septic arthritis. Cases in patients who were immunocompromised, at extremes age or had history steroid injection penetrating trauma. A 67-year-old man with a opioid use disorder, osteoarthritis, and gout but no known immunocompromise was admitted hospital pain swelling his right knee. Cultures synovial fluid urine grew complex. Microscopy also identified intracellular calcium pyrophosphate crystals. The patient’s...
Abstract Background Intravenous (IV) vancomycin is commonly used to treat MRSA (methicillin-resistant Staphylococcus aureus) infections and typically dosed at 15 mg/kg every 12 hours. Pharmacokinetic studies, animal models, limited human study suggest that once-daily high dose (30 mg/kg) similar in efficacy for certain types of infection the hospital setting, but there little evidence its use outpatient antibiotic therapy (OPAT). We have a regimen skin soft-tissue (SSTI) since 2011. describe...
Klebsiella variicola (K. variicola) is a Gram-negative organism genetically similar to pneumoniae pneumoniae) that can cause variety of diseases in humans. Bacteremia due K. associated with higher mortality rate than bacteremia pneumoniae. Here, we describe 65-year-old woman who developed pyelonephritis 2 months after receiving renal transplantation following longstanding history end-stage disease secondary polycystic kidney disease. Her creatinine on admission was unchanged from her...